Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Antagonism of miRNA in heart failure: first evidence in human.

European heart journal

Baker AH, Giacca M.
PMID: 33338200
Eur Heart J. 2021 Jan 07;42(2):189-191. doi: 10.1093/eurheartj/ehaa967.

No abstract available.

Cite
Baker AH, Giacca M. Antagonism of miRNA in heart failure: first evidence in human. Eur Heart J. 2021;42(2):189-191doi: 10.1093/eurheartj/ehaa967.
Baker, A. H., & Giacca, M. (2021). Antagonism of miRNA in heart failure: first evidence in human. European heart journal, 42(2), 189-191. https://doi.org/10.1093/eurheartj/ehaa967
Baker, Andrew H, and Giacca, Mauro. "Antagonism of miRNA in heart failure: first evidence in human." European heart journal vol. 42,2 (2021): 189-191. doi: https://doi.org/10.1093/eurheartj/ehaa967
Baker AH, Giacca M. Antagonism of miRNA in heart failure: first evidence in human. Eur Heart J. 2021 Jan 07;42(2):189-191. doi: 10.1093/eurheartj/ehaa967. PMID: 33338200; PMCID: PMC7816691.
Copy Download .nbib Format: NLM
Genetic Contribution to Common Heart Failure-Not So Rare?.

JAMA cardiology

McNally EM, O'Donnell CJ.
PMID: 33325982
JAMA Cardiol. 2021 Apr 01;6(4):387. doi: 10.1001/jamacardio.2020.6508.

No abstract available.

Cite
McNally EM, O'Donnell CJ. Genetic Contribution to Common Heart Failure-Not So Rare?. JAMA Cardiol. 2021;6(4):387doi: 10.1001/jamacardio.2020.6508.
McNally, E. M., & O'Donnell, C. J. (2021). Genetic Contribution to Common Heart Failure-Not So Rare?. JAMA cardiology, 6(4), 387. https://doi.org/10.1001/jamacardio.2020.6508
McNally, Elizabeth M, and O'Donnell, Christopher J. "Genetic Contribution to Common Heart Failure-Not So Rare?." JAMA cardiology vol. 6,4 (2021): 387. doi: https://doi.org/10.1001/jamacardio.2020.6508
McNally EM, O'Donnell CJ. Genetic Contribution to Common Heart Failure-Not So Rare?. JAMA Cardiol. 2021 Apr 01;6(4):387. doi: 10.1001/jamacardio.2020.6508. PMID: 33325982.
Copy Download .nbib Format: NLM
Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study.

Diabetes care

Mordi IR, Lumbers RT, Palmer CNA, Pearson ER, Sattar N, Holmes MV, Lang CC.
PMID: 34088700
Diabetes Care. 2021 Jul;44(7):1699-1705. doi: 10.2337/dc20-2518. Epub 2021 Jun 04.

OBJECTIVE: The aim of this study was to use Mendelian randomization (MR) techniques to estimate the causal relationships between genetic liability to type 2 diabetes (T2D), glycemic traits, and risk of heart failure (HF).RESEARCH DESIGN AND METHODS: Summary-level data...

Cite
Mordi IR, Lumbers RT, Palmer CNA, et al. Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study. Diabetes Care. 2021;44(7):1699-1705doi: 10.2337/dc20-2518.
Mordi, I. R., Lumbers, R. T., Palmer, C. N. A., Pearson, E. R., Sattar, N., Holmes, M. V., Lang, C. C. (2021). Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study. Diabetes care, 44(7), 1699-1705. https://doi.org/10.2337/dc20-2518
Mordi, Ify R, et al. "Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study." Diabetes care vol. 44,7 (2021): 1699-1705. doi: https://doi.org/10.2337/dc20-2518
Mordi IR, Lumbers RT, Palmer CNA, Pearson ER, Sattar N, Holmes MV, Lang CC. Type 2 Diabetes, Metabolic Traits, and Risk of Heart Failure: A Mendelian Randomization Study. Diabetes Care. 2021 Jul;44(7):1699-1705. doi: 10.2337/dc20-2518. Epub 2021 Jun 04. PMID: 34088700; PMCID: PMC8323186.
Copy Download .nbib Format: NLM
Rare Diseases in Cardiovascular Medicine II.

European heart journal

Majid Akhtar M, Elliott PM.
PMID: 30052875
Eur Heart J. 2017 Jun 01;38(21):1629-1631. doi: 10.1093/eurheartj/ehx242.

No abstract available.

Cite
Majid Akhtar M, Elliott PM. Rare Diseases in Cardiovascular Medicine II. Eur Heart J. 2017;38(21):1629-1631doi: 10.1093/eurheartj/ehx242.
Majid Akhtar, M., & Elliott, P. M. (2017). Rare Diseases in Cardiovascular Medicine II. European heart journal, 38(21), 1629-1631. https://doi.org/10.1093/eurheartj/ehx242
Majid Akhtar, Mohammed, and Elliott, Perry M. "Rare Diseases in Cardiovascular Medicine II." European heart journal vol. 38,21 (2017): 1629-1631. doi: https://doi.org/10.1093/eurheartj/ehx242
Majid Akhtar M, Elliott PM. Rare Diseases in Cardiovascular Medicine II. Eur Heart J. 2017 Jun 01;38(21):1629-1631. doi: 10.1093/eurheartj/ehx242. PMID: 30052875.
Copy Download .nbib Format: NLM
Genomes, proteomes, and the central dogma.

Circulation. Cardiovascular genetics

Franklin S, Vondriska TM.
PMID: 22010165
Circ Cardiovasc Genet. 2011 Oct;4(5):576. doi: 10.1161/CIRCGENETICS.110.957795.

Systems biology, with its associated technologies of proteomics, genomics, and metabolomics, is driving the evolution of our understanding of cardiovascular physiology. Rather than studying individual molecules or even single reactions, a systems approach allows integration of orthogonal data sets...

Cite
Franklin S, Vondriska TM. Genomes, proteomes, and the central dogma. Circ Cardiovasc Genet. 2011;4(5):576doi: 10.1161/CIRCGENETICS.110.957795.
Franklin, S., & Vondriska, T. M. (2011). Genomes, proteomes, and the central dogma. Circulation. Cardiovascular genetics, 4(5), 576. https://doi.org/10.1161/CIRCGENETICS.110.957795
Franklin, Sarah, and Vondriska, Thomas M. "Genomes, proteomes, and the central dogma." Circulation. Cardiovascular genetics vol. 4,5 (2011): 576. doi: https://doi.org/10.1161/CIRCGENETICS.110.957795
Franklin S, Vondriska TM. Genomes, proteomes, and the central dogma. Circ Cardiovasc Genet. 2011 Oct;4(5):576. doi: 10.1161/CIRCGENETICS.110.957795. PMID: 22010165; PMCID: PMC3200573.
Copy Download .nbib Format: NLM
Epigenetic Regulation of Heart Failure: Cell Type Matters.

Circulation research

Padula SL, Yutzey KE.
PMID: 34292781
Circ Res. 2021 Jul 23;129(3):414-416. doi: 10.1161/CIRCRESAHA.121.319642. Epub 2021 Jul 22.

No abstract available.

Cite
Padula SL, Yutzey KE. Epigenetic Regulation of Heart Failure: Cell Type Matters. Circ Res. 2021;129(3):414-416doi: 10.1161/CIRCRESAHA.121.319642.
Padula, S. L., & Yutzey, K. E. (2021). Epigenetic Regulation of Heart Failure: Cell Type Matters. Circulation research, 129(3), 414-416. https://doi.org/10.1161/CIRCRESAHA.121.319642
Padula, Stephanie L, and Yutzey, Katherine E. "Epigenetic Regulation of Heart Failure: Cell Type Matters." Circulation research vol. 129,3 (2021): 414-416. doi: https://doi.org/10.1161/CIRCRESAHA.121.319642
Padula SL, Yutzey KE. Epigenetic Regulation of Heart Failure: Cell Type Matters. Circ Res. 2021 Jul 23;129(3):414-416. doi: 10.1161/CIRCRESAHA.121.319642. Epub 2021 Jul 22. PMID: 34292781; PMCID: PMC8544613.
Copy Download .nbib Format: NLM
Race-based therapeutics: a discussion surrounding heart failure trials.

JAAPA : official journal of the American Academy of Physician Assistants

Schmitz N.
PMID: 17319388
JAAPA. 2007 Feb;20(2):24-8. doi: 10.1097/01720610-200702000-00014.

No abstract available.

Cite
Schmitz N. Race-based therapeutics: a discussion surrounding heart failure trials. JAAPA. 2007;20(2):24-8doi: 10.1097/01720610-200702000-00014.
Schmitz, N. (2007). Race-based therapeutics: a discussion surrounding heart failure trials. JAAPA : official journal of the American Academy of Physician Assistants, 20(2), 24-8. https://doi.org/10.1097/01720610-200702000-00014
Schmitz, Natalie. "Race-based therapeutics: a discussion surrounding heart failure trials." JAAPA : official journal of the American Academy of Physician Assistants vol. 20,2 (2007): 24-8. doi: https://doi.org/10.1097/01720610-200702000-00014
Schmitz N. Race-based therapeutics: a discussion surrounding heart failure trials. JAAPA. 2007 Feb;20(2):24-8. doi: 10.1097/01720610-200702000-00014. PMID: 17319388.
Copy Download .nbib Format: NLM
Cardiac remodeling and failure: from molecules to man (Part I).

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology

Fedak PW, Verma S, Weisel RD, Li RK.
PMID: 15710285
Cardiovasc Pathol. 2005 Jan-Feb;14(1):1-11. doi: 10.1016/j.carpath.2004.12.002.

The process of heart failure appears to be a common and coordinated response to cardiac injury and dysfunction. The contemporary mechanistic viewpoint that predictable, shared, highly regulated events underlie the complex heart failure process implies that an improved understanding...

Cite
Fedak PW, Verma S, Weisel RD, et al. Cardiac remodeling and failure: from molecules to man (Part I). Cardiovasc Pathol. 2005;14(1):1-11doi: 10.1016/j.carpath.2004.12.002.
Fedak, P. W., Verma, S., Weisel, R. D., & Li, R. K. (2005). Cardiac remodeling and failure: from molecules to man (Part I). Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, 14(1), 1-11. https://doi.org/10.1016/j.carpath.2004.12.002
Fedak, Paul W M, et al. "Cardiac remodeling and failure: from molecules to man (Part I)." Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology vol. 14,1 (2005): 1-11. doi: https://doi.org/10.1016/j.carpath.2004.12.002
Fedak PW, Verma S, Weisel RD, Li RK. Cardiac remodeling and failure: from molecules to man (Part I). Cardiovasc Pathol. 2005 Jan-Feb;14(1):1-11. doi: 10.1016/j.carpath.2004.12.002. PMID: 15710285.
Copy Download .nbib Format: NLM
Systems biology and heart failure: concepts, methods, and potential research applications.

Heart failure reviews

Adams KF.
PMID: 19396630
Heart Fail Rev. 2010 Jul;15(4):371-98. doi: 10.1007/s10741-009-9138-x.

Dramatic advances in molecular biology dominated twentieth century biomedical science and delineated the function of individual genes and molecules in exquisite detail. However, biological processes cannot be fully understood based on the properties of individual genes and molecules alone,...

Cite
Adams KF. Systems biology and heart failure: concepts, methods, and potential research applications. Heart Fail Rev. 2010;15(4):371-98doi: 10.1007/s10741-009-9138-x.
Adams, K. F. (2010). Systems biology and heart failure: concepts, methods, and potential research applications. Heart failure reviews, 15(4), 371-98. https://doi.org/10.1007/s10741-009-9138-x
Adams, Kirkwood F. "Systems biology and heart failure: concepts, methods, and potential research applications." Heart failure reviews vol. 15,4 (2010): 371-98. doi: https://doi.org/10.1007/s10741-009-9138-x
Adams KF. Systems biology and heart failure: concepts, methods, and potential research applications. Heart Fail Rev. 2010 Jul;15(4):371-98. doi: 10.1007/s10741-009-9138-x. PMID: 19396630.
Copy Download .nbib Format: NLM
Preface. Genetic studies of primary forms of heart failure.

Heart failure clinics

MacRae CA.
PMID: 20347782
Heart Fail Clin. 2010 Apr;6(2):xv-xvi. doi: 10.1016/j.hfc.2009.12.006.

No abstract available.

Cite
MacRae CA. Preface. Genetic studies of primary forms of heart failure. Heart Fail Clin. 2010;6(2):xv-xvidoi: 10.1016/j.hfc.2009.12.006.
MacRae, C. A. (2010). Preface. Genetic studies of primary forms of heart failure. Heart failure clinics, 6(2), xv-xvi. https://doi.org/10.1016/j.hfc.2009.12.006
MacRae, Calum A. "Preface. Genetic studies of primary forms of heart failure." Heart failure clinics vol. 6,2 (2010): xv-xvi. doi: https://doi.org/10.1016/j.hfc.2009.12.006
MacRae CA. Preface. Genetic studies of primary forms of heart failure. Heart Fail Clin. 2010 Apr;6(2):xv-xvi. doi: 10.1016/j.hfc.2009.12.006. PMID: 20347782.
Copy Download .nbib Format: NLM
Perspective on precision medicine in paediatric heart failure.

Clinical science (London, England : 1979)

Fridman MD, Mital S.
PMID: 28265035
Clin Sci (Lond). 2017 Mar 01;131(6):439-448. doi: 10.1042/CS20160414.

In 2015, President Obama launched the Precision Medicine Initiative (PMI), which introduced new funding to a method of research with the potential to study rare and complex diseases. Paediatric heart failure, a heterogeneous syndrome affecting approximately 1 in 100000...

Cite
Fridman MD, Mital S. Perspective on precision medicine in paediatric heart failure. Clin Sci (Lond). 2017;131(6):439-448doi: 10.1042/CS20160414.
Fridman, M. D., & Mital, S. (2017). Perspective on precision medicine in paediatric heart failure. Clinical science (London, England : 1979), 131(6), 439-448. https://doi.org/10.1042/CS20160414
Fridman, Michael D, and Mital, Seema. "Perspective on precision medicine in paediatric heart failure." Clinical science (London, England : 1979) vol. 131,6 (2017): 439-448. doi: https://doi.org/10.1042/CS20160414
Fridman MD, Mital S. Perspective on precision medicine in paediatric heart failure. Clin Sci (Lond). 2017 Mar 01;131(6):439-448. doi: 10.1042/CS20160414. PMID: 28265035.
Copy Download .nbib Format: NLM
Heart failure entails significant changes in human nucleocytoplasmic transport gene expression.

International journal of cardiology

Molina-Navarro MM, Roselló-Lletí E, Tarazón E, Ortega A, Sánchez-Izquierdo D, Lago F, González-Juanatey JR, García-Pavía P, Salvador A, Montero JA, Portolés M, Rivera M.
PMID: 23651824
Int J Cardiol. 2013 Oct 03;168(3):2837-43. doi: 10.1016/j.ijcard.2013.03.192. Epub 2013 May 04.

BACKGROUND: Heart failure (HF) induces alterations in nucleocytoplasmic transport, which is essential to the cardiomyocyte biology. The objective of this study was to analyze the changes in gene expression in human HF, particularly focusing on nucleocytoplasmic transport-related genes.METHODS AND...

Cite
Molina-Navarro MM, Roselló-Lletí E, Tarazón E, et al. Heart failure entails significant changes in human nucleocytoplasmic transport gene expression. Int J Cardiol. 2013;168(3):2837-43doi: 10.1016/j.ijcard.2013.03.192.
Molina-Navarro, M. M., Roselló-Lletí, E., Tarazón, E., Ortega, A., Sánchez-Izquierdo, D., Lago, F., González-Juanatey, J. R., García-Pavía, P., Salvador, A., Montero, J. A., Portolés, M., & Rivera, M. (2013). Heart failure entails significant changes in human nucleocytoplasmic transport gene expression. International journal of cardiology, 168(3), 2837-43. https://doi.org/10.1016/j.ijcard.2013.03.192
Molina-Navarro, Maria Micaela, et al. "Heart failure entails significant changes in human nucleocytoplasmic transport gene expression." International journal of cardiology vol. 168,3 (2013): 2837-43. doi: https://doi.org/10.1016/j.ijcard.2013.03.192
Molina-Navarro MM, Roselló-Lletí E, Tarazón E, Ortega A, Sánchez-Izquierdo D, Lago F, González-Juanatey JR, García-Pavía P, Salvador A, Montero JA, Portolés M, Rivera M. Heart failure entails significant changes in human nucleocytoplasmic transport gene expression. Int J Cardiol. 2013 Oct 03;168(3):2837-43. doi: 10.1016/j.ijcard.2013.03.192. Epub 2013 May 04. PMID: 23651824.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries